Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ASST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 1.349B
March 31, 2026 1.074B
December 31, 2025 731.24M
September 30, 2025 779.43M
June 30, 2025 2.684M
March 31, 2025 4.534M
December 31, 2024 2.787M
September 30, 2024 2.256M
June 30, 2024 2.097M
March 31, 2024 1.862M
Date Value
December 31, 2023 2.922M
September 30, 2023 4.016M
June 30, 2023 4.906M
March 31, 2023 5.823M
December 31, 2022 0.1538M
September 30, 2022 0.031M
June 30, 2022 0.1147M
March 31, 2022 0.1849M
December 31, 2021 0.2691M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Daxor Corp. --
Meridian Holdings, Inc. (California) -2.323M
SkyAI, Inc. 157.28M
Hyperliquid Strategies, Inc. 1.873B
TransMedics Group, Inc. 518.05M

Shareholders Equity (Quarterly) Related Metrics